Overview
Fathi Yusuf practices practicing medicine in Mogadishu, Somalia.
Her clinical expertise encompasses Leukocytosis, Amenorrhea, Low Potassium Level, and Lymphofollicular Hyperplasia.
She is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Fathi Y. Yusuf
Is Fathi Y. Yusuf a top-rated expert for Leukocytosis?
MediFind is an objective health platform that identifies experts based on real-world data. Fathi Y. Yusuf is classified as an Experienced expert for Leukocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Fathi Y. Yusuf participate in research or clinical trials?
Yes. Fathi Y. Yusuf has published 10 articles and abstracts on conditions like Leukocytosis. You can view a list of Fathi Y. Yusuf's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AmenorrheaMs. Yusuf isExperienced. Learn about Amenorrhea.
- LeukocytosisMs. Yusuf isExperienced. Learn about Leukocytosis.
- Low Potassium LevelMs. Yusuf isExperienced. Learn about Low Potassium Level.
- Lymphofollicular HyperplasiaMs. Yusuf isExperienced. Learn about Lymphofollicular Hyperplasia.